Mark has been a part of the investment team since its inception. In his time at OS Fund he has led diligence and worked on dozens of deals across Genomics,Synthetic Biology, and Advanced Materials. Mark has served as Board Advisor to multiple companies including Health Data Link (acquired by Datavant, 2019). He has over a decade of investment experience across multiple asset classes. Mark attended Indiana University and is a CFA charterholder.
Return to Team